Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

International Symposium on Clinical and Basic Investigation in Glioblastoma

FOR INFORMATION AND REGISTRATION, VISIT

http://www.fundacioncac.es/eng/fundacion/actividades/actividadesficha.jsp?idActividad=111

Preliminary program

Plenary session I: Clinical Research on GBM

Eric Holland. Brain Tumor Center, Departments of Neurosurgery, Surgery & Neurology, Memorial Sloan Kettering Cancer Center. New York, USA.
Molecular classification of glioblastoma. Therapeutic implications in  modern neurooncology

Alfredo Quiñones-Hinojosa. Department of Neurosurgery. Johns Hopkins Hospital. Johns Hopkins University. Baltimore, USA.
Recent advances in brain tumor surgery. Local intracerebral drug delivery

Roger Stupp. Multidisciplinary Oncology Center, University of Lausanne Hospitals. Lausanne, Switzerland.
Emerging therapeutic strategies in the management of glioblastoma

Martin J. van den Bent. Department of Neuro-Oncology. Erasmus MC Daniel den Hoed Oncology Center. Rotterdam, The Netherlands.
Glioblastoma: are we approaching personalized medicine?

Jeremy Rees. National Hospital for Neurology and Neurosurgery. London, UK
Imaging biomarkers in glioblastoma

Juan Fueyo. Department of Neuro-Oncology - Research, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, USA.
Gene therapy in neurooncology

Emiliano Calvo Aller. START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Norte Sanchinarro. Madrid, Spain.
Early clinical drug development in Neurooncology


Plenary session II: Basic Research on GBM and Gliomagenesis

Peter B. Dircks. Division of Neurosurgery. Program in Developmental and Stem Cell Biology, Hospital for Sick Children, University of Toronto. Toronto, Canada.
Isolation of cancer initiating cells from human glioblastoma

Angelo L. Vescovi. Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
Heterogeneity of cancer initiating cells within human GBM

Jeremy N. Rich. Department of Stem Cell Biology and Regenerative Medicine Cleveland, USA.
Hypoxia microenviroment in glioblastoma initiating cells

Hiroko Ohgaki. Section of Molecular Pathology, International Agency for Research on Cancer. World Health Organization (WHO). Lyon, France.
Molecular alterations in gliomas

Rossella Galli. Neural Stem Cell Biology Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute. Milan, Italy.
Tyrosine kinase receptors determine the nature of cancer initiating cells from glioblastoma

Bernhard Radlwimmer. Division of Molecular Genetics, German Cancer Research Center (DKFZ). Heidelberg, Germany.
Molecular signature of gliomas

Suzanne Baker. Developmental Neurobiology. St. Jude Children's Research Hospital. Memphis, USA.
Molecular genetic profiling of pediatric glioblastoma


Plenary session III: New Therapeutic Approaches for GBM Treatment

Philip De Witt Hamer. VU medisch centrum, Afdeling Neurochirurgie. Amsterdam, The Netherlands.
Protein kinase inhibitors for the treatment of glioblastoma

Tracy T. Batchelor. Massachusetts General Hospital. Boston, USA.
Vascular endothelial growth factor inhibitors in gliomas
Speaker

Organizer Cátedra Santiago Grisolía

When?

Thu, Jun. 23 - Fri, Jun. 24, 2011
7 a.m. - 2 p.m.
(GMT-0600) US/Central

Where?

Santiago Grisolía Auditorium at the Museo de las Ciencias Príncipe Felipe of Valencia
Av. Autopista del Saler, 7
Valencia
Spain